Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Is it safe in humans
The Impact of Glucagon-Like Peptide-1 Receptor Agonists on Kidney Outcomes A Meta-Analysis of Randomized Placebo-Controlled Trials Lus Mendona 1 , 2 Henrique Moura 1 Paulo Castro Chaves 1 , 3 Joo Srgio Neves 1 , 4 Joo Pedro Ferreira 1 , 5 Key Points This is an updated meta-analysis about glucagon-like peptide-1 receptor agonists (GLP-1 RAs) incorporating findings from the recently published FLOW and SELECT studies
for intramyocellular and extramyocellular lipids (IMCL and EMCL), creatine (Cr), components containing trimethylamine (TMA) group, and acetyl-carnitine detection (water non-suppressed spectra with TE = 280 ms, TR = 2 s and number of transients = 64) [45,46,47]
doi: 10.1021/jf991106k 9
The opportunity to contribute to obesity research that could lead to improved treatments in the future
